DeutschNewstral
Article
Star Tribune on 2020-08-09 02:20
UnitedHealth Group studies COVID-19 risks with sickle cell
Related news
Morehouse studying COVID-19 and Sickle Cellatlantadailyworld.com- UnitedHealth Group shifts to work-from-homeStar Tribune
- UnitedHealth Group shuffles top executivesStar Tribune
- UnitedHealth Group names new presidentStar Tribune
- UnitedHealth Group moves Minnesota headquarters from Minnetonka to Eden PrairieStar Tribune
- UnitedHealth Group launches COVID-19 at-home treatment studyStar Tribune
Seattle-based Polyclinic being sold to UnitedHealth GroupSeattle Times- Fourth-quarter profit surges past $4 billion at UnitedHealth GroupStar Tribune
- HUnitedHealth Group Targeted by Whistleblower Lawsuithamodia.com
For Minnesotans suffering with sickle cell, FDA delivers new hopeAustin Daily Herald- Report: Notorious ransomware group launched cyberattack on UnitedHealth GroupStar Tribune
- US Labor Department sues UnitedHealth Group over denied claims - Wed, 02 Aug 2023 PSTStar Tribune
- UnitedHealth Group to require COVID-19 vaccine for many U.S. employeesStar Tribune
- UnitedHealth Group expects systems impacted by cyberattack returning by mid-MarchStar Tribune
- UnitedHealth Group profit doubles to $6.6 billion with COVID-19 slowdownStar Tribune
- UnitedHealth Group pushes self-collected COVID-19 testStar Tribune
- Justice Department appeals ruling in UnitedHealth Group antitrust caseStar Tribune
- Fallout grows from cyberattack at UnitedHealth Group subsidiaryStar Tribune
- UnitedHealth Group sees growing demand for behavioral health careStar Tribune
- UnitedHealth Group is big on workers getting skinnyStar Tribune